FDA Approves Less Frequent Lebrikizumab Dosing

• by Kathryn Wighton

• June 10, 2026

Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

• by Małgorzata Kowacka, Michał Dec, Hubert Arasiewicz

• May 20, 2026

Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis

• by Jonathan I. Silverberg, Eric L. Simpson, Saleem A. Farooqui, Gary Chan, Pinaki Biswas, Erman Güler

• May 20, 2026

Medical Oddities: Prayer for Pain?

This week’s research collection showed that biology, behavior, and environment often intersect in unexpected ways.

• by Teraya Smith

• June 3, 2026

• 6 min